Nucleai
Chicago
About Nucleai
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies, licensing its research platform for internal use, and collaborating in biomarkers discovery projects.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $60.5M
- Last round: Series Unknown (Apr 2024)
- Website: nucleai.ai
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Health Care, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/nucleai-58495 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.